Precigen (PGEN) FCF Margin Growth (1y) (2013 - 2026)
Powered by 
Analysis
Precigen (PGEN) FCF Margin Growth (1y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn | 682.00 |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - | 1.20 Mn |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn | 5,823.00 |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | -189.00 |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn | 26,580.00 |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - | -1.30 Mn |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn | 226,818.00 |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn | 1,141.00 |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn | 1,854.00 |
| 10 | Taysha Gene Therapies | 1.97 Bn | 1.97 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 226,818.00 |
| Mar 31, 2026 | 109,236.00 |
| Dec 31, 2025 | 26,477.00 |
| Sep 30, 2025 | 146,982.00 |
| Jun 30, 2025 | 124,544.00 |
| Mar 31, 2025 | 44,960.00 |
| Dec 31, 2024 | 56,702.00 |
| Sep 30, 2024 | -120,712.00 |
| Jun 30, 2024 | -264,865.00 |
| Mar 31, 2024 | -72,982.00 |
| Dec 31, 2023 | -46,980.00 |
| Sep 30, 2023 | -111,903.00 |
| Jun 30, 2023 | -59,677.00 |
| Mar 31, 2023 | -63,238.00 |
| Dec 31, 2022 | -40,501.00 |
| Sep 30, 2022 | 42,688.00 |
| Jun 30, 2022 | -6,618.00 |
| Mar 31, 2022 | -29,836.00 |
| Dec 31, 2021 | -37,850.00 |
| Sep 30, 2021 | -49,377.00 |